GranuFlo Recall Litigation Grows, as Bernstein Liebhard LLP Notes the Filing of Nearly A Dozen New GranuFlo and NaturaLyte Lawsuits

Share Article

The Firm is representing numerous GranuFlo lawsuit clients who allegedly suffered serious cardiovascular complications related to the 2012 recall of GranuFlo and NaturaLyte dialysis concentrates.

Free Case Review
Our Firm is representing numerous GranuFlo lawsuit plaintiffs who have put forth similar claims against Fresenius Medical Care. We are closely monitoring the growing litigation surrounding this matter.

GranuFlo lawsuits ( filed on behalf of dialysis patients who were allegedly harmed by products included in the 2012 GranuFlo and NaturaLyte recall continue to mount in state and federal courts throughout the U.S., Bernstein Liebhard LLP reports. According to The Glasgow Daily Times, 11 new claims were recently filed in Kentucky’s Barren Circuit Court on behalf of individuals who suffered fatal cardiovascular events that were allegedly caused by the administration of GranuFlo or NaturaLyte during dialysis treatments. Like thousands of other GranuFlo and NaturaLyte claims pending in U.S. courts, these cases assert claims of negligence, breaches of warranty, fraud, and violation of consumer protection laws. The complaints also seek loss of consortium for spouses and family members of the deceased, as well as wrongful death.*

“Our Firm is representing numerous GranuFlo lawsuit plaintiffs who have put forth similar claims against Fresenius Medical Care. We are closely monitoring the growing litigation surrounding this matter,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free GranuFlo lawsuit evaluations to dialysis patients who allegedly suffered cardiac arrest, heart attacks, stroke, sudden cardiac death or other side effects within 72 hours of a dialysis treatment involving the use of GranuFlo or NaturaLyte dialysis drugs.
GranuFlo and NaturaLyte Recall Litigation

GranuFlo and NaturaLyte are both dialysis concentrates that are used during treatments to remove toxins from patients’ blood. In March 2012, Fresenius Medical Care issued an Urgent Product Notification for both concentrates that warned of dosage issues that could put patients at risk for serious and potentially life-threatening heart side effects. The U.S. Food & Drug Administration (FDA) ultimately granted Class I recall status to the Urgent Product Notification, which indicates that a medical product poses a risk of serious injury or death.

Since the announcement of the GranuFlo recall, court records indicate that thousands of lawsuits have been filed across the country on behalf of individuals who allegedly suffered heart attacks, strokes, and other serious cardiovascular events due to the administration of GranuFlo and NaturaLyte. This includes more than 2,220 cases that are now pending in a federal multidistrict litigation now underway in U.S. District Court, District of Massachusetts, where Bernstein Liebhard LLP is currently filing claims. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428) Additional GranuFlo and NaturaLyte Lawsuits have also been consolidated on the state level in Massachusetts’ Middlesex County Superior Court, where more than 3,900 claims have been filed. (In re: Consolidated Fresenius Cases, No. MICV2013-03400-O).

Dialysis patients who experienced life-threatening cardiovascular events that were allegedly caused by GranuFlo or NaturaLyte may be entitled to join this growing litigation. To learn more about filing a GranuFlo lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: For additional information, and to arrange for a free case review, please call 800-511-5092.

*, Glasgow Daily Times, October 24, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website